Literature DB >> 19336546

Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies.

.   

Abstract

High-risk human papillomavirus (HPV) types cause most cervical carcinomas and are sexually transmitted. Sexual behavior therefore affects HPV exposure and its cancer sequelae. The International Collaboration of Epidemiological Studies of Cervical Cancer has combined data on lifetime number of sexual partners and age at first sexual intercourse from 21 studies, or groups of studies, including 10,773 women with invasive cervical carcinoma, 4,688 women with cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ, and 29,164 women without cervical carcinoma. Relative risks for invasive cancer and CIN3 were estimated by conditional logistic regression. Risk of invasive cervical carcinoma increased with lifetime number of sexual partners (P for linear trend <0.001). The relative risk for > or =6 versus 1 partner, conditioned on age, study, and age at first intercourse, was 2.27 [95% confidence interval (95% CI), 1.98-2.61] and increased to 2.78 (95% CI, 2.22-3.47) after additional conditioning on reproductive factors. The risk of invasive cervical carcinoma increased with earlier age at first intercourse (P for linear trend <0.001). The relative risk for age at first intercourse < or =14 versus > or =25 years, conditioned on age, study, and lifetime number of sexual partners was 3.52 (95% CI, 3.04-4.08), which decreased to 2.05 (95% CI, 1.54-2.73) after additional conditioning on reproductive factors. CIN3/carcinoma in situ showed a similar association with lifetime number of sexual partners; however, the association with age at first intercourse was weaker than for invasive carcinoma. Results should be interpreted with caution given the strong correlation between sexual and reproductive factors and the limited information on HPV status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336546     DOI: 10.1158/1055-9965.EPI-08-1186

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

Review 1.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

Review 2.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

3.  Evidence that supports policies to delay cervical screening until after age 25 years.

Authors:  James A Dickinson; Gina Ogilvie; Dirk Van Niekerk; Cathy Popadiuk
Journal:  CMAJ       Date:  2017-03-13       Impact factor: 8.262

4.  Time since first sexual intercourse and the risk of cervical cancer.

Authors:  Martyn Plummer; Julian Peto; Silvia Franceschi
Journal:  Int J Cancer       Date:  2011-08-12       Impact factor: 7.396

5.  Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy.

Authors:  Julia W Gargano; Rosane Nisenbaum; Daisy R Lee; Mack T Ruffin; Martin Steinau; Ira R Horowitz; Lisa C Flowers; Talaat S Tadros; George Birdsong; Elizabeth R Unger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

6.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

7.  South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates.

Authors:  E Singh; J M Underwood; C Nattey; C Babb; M Sengayi; P Kellett
Journal:  S Afr Med J       Date:  2015-01-12

Review 8.  Metastatic gynecologic malignancies: advances in treatment and management.

Authors:  John K Chan; Stephanie Chow; Subasish Bhowmik; Amandeep Mann; Daniel S Kapp; Robert L Coleman
Journal:  Clin Exp Metastasis       Date:  2018-06-21       Impact factor: 5.150

9.  Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial.

Authors:  Mónica S Sierra; Sabrina H Tsang; Shangying Hu; Carolina Porras; Rolando Herrero; Aimée R Kreimer; John Schussler; Joseph Boland; Sarah Wagner; Bernal Cortes; Ana C Rodríguez; Wim Quint; Leen-Jan van Doorn; Mark Schiffman; Joshua N Sampson; Allan Hildesheim
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

10.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.